Embark Veterinary fetches $10 mln Series A
Boston-based Embark Veterinary Inc, a dog genetics company, has raised $10 million in Series A funding. F-Prime Capital led the round with participation from return backers including Slow Ventures, Section 32, Third Kind Venture Capital, Freestyle Capital, FJ Labs and Anne Wojciciki, CEO of 23andme.
11 April 2019•1 min read
